Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page

Combined Hormonal Contraceptives & Migraine

On Demand Sessions:

Expiration Date Presenter Are you seeking credit?
September 8, 2018 Pelin Batur, MD, FACP, NCMP, CCD and Anne H. Calhoun, MD, FAHS Review webinar for CME/CE credit*

Review webinar without credit

*By clicking the webinar with credit link, you confirm that you have read the accreditation information on this page.

This is a one-hour internet-based activity. To receive continuing education credit, learners should 1) take the pre-test 2) review the webinar and 3) complete the post-test.

Learning Objectives

By the end of this presentation, you will be able to:
  • Diagnosis migraines and describe their epidemiology
  • Describe some of the neurologic consequences to declines in estrogen concentration
  • Explain the controversy regarding stroke risk and migraine with aura, and how these risks are altered with different CHCs
  • Counsel women with migraines on their contraceptive options

Accreditation Information

Nurse Practitioners and Nurses: ARHP is approved by the California Board of Registered Nursing, Provider Number 16643, to provide nursing continuing education credits. This live activity is approved for 1.0 contact hour.

Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit™.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through an educational grant from Amgen Inc.

Target Audience

The intended audiences for this activity are health professionals who provide reproductive health services, including physicians, nurse practitioners, nurse-midwives, physician assistants, educators, researchers, and other professionals who work in obstetrics/gynecology, family medicine, and related fields.


All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

  • Pelin Batur MD, NCMP, CCD (Program planner and faculty) has nothing to disclose.
  • Anne H. Calhoun, MD, FAHS (Program planner and faculty) is a consultant for Depomed, Lilly, and Teva. She provides research support for Autonomic Technologies, ElectroCore, Scion, and Neurostim. She is a speaker for Avanir, Sepomed, Merck, Pernix, and Teva.
  • Emily Kane-Lee, MPH (ARHP program manager) has nothing to disclose.